Editors' picks

Lifeline or gamble? Sometimes a clinical trail is both

The human subjects trade is booming, largely without oversight

Solutions from stanford

Serving in clinical trials offers lessons for living

Why nothing really is something, and in some ways is better than anything

Musings on why evidence can persuade, but a good story compels

Minds of all kinds join to hasten discoveries of new medical treatments

Q&A with a drug trials overseer

Doubts mount over move to end off-label drug oversight

Stanford's medical school: from fractious to pre-eminent present